Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

por Inusa, Baba Psalm Duniya, Atoyebi, Wale, Hassan, Abdul Aziz, Idhate, Tushar, Dogara, Livingstone, Ijei, Ifeoma, Qin, Yewen, Anie, Kofi, Lawson, Juliana Olufunke, Hsu, Lewis
Publicado 2018

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges

por Nnodu, Obiageli, Isa, Hezekiah, Nwegbu, Maxwell, Ohiaeri, Chinatu, Adegoke, Samuel, Chianumba, Reuben, Ugwu, Ngozi, Brown, Biobele, Olaniyi, John, Okocha, Emmanuel, Lawson, Juliet, Hassan, Abdul-Aziz, Diaku-Akinwumi, Ijeoma, Madu, Anazoeze, Ezenwosu, Osita, Tanko, Yohanna, Kangiwa, Umar, Girei, Ahmed, Israel-Aina, Yetunde, Ladu, Adama, Egbuzu, Perpetua, Abjah, Usman, Okolo, Angela, Akbulut-Jeradi, Nagihan, Fernandez, Maria, Piel, Frédéric B., Adekile, Adekunle
Publicado 2019

Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders

por Isa, Hezekiah, Okocha, Emmanuel, Adegoke, Samuel Ademola, Nnebe-Agumadu, Uche, Kuliya-Gwarzo, Aisha, Sopekan, Alayo, Ofakunrin, Akinyemi Olugbenga, Ugwu, Ngozi, Hassan, Abdul-Aziz, Ohiaeri, Chinatu, Madu, Anazoeze, Diaku-Akinwumi, Ijeoma, Ekwem, Lilian, Dogara, Livingstone Gayus, Okoh, Dorothy, Jasini, James, Girei, Ahmed, Ekwere, Timothy, Okolo, Angela, Kangiwa, Umar, Lawson, Juliet, Chianumba, Reuben, Brown, Biobele, Akinola, Norah, Nwegbu, Maxwell, Nnodu, Obiageli
Publicado 2023